Catrin Treharne
She/Her
Partner and Health Economics Lead
I am a Partner and Health Economics Lead in the Health Analytics team, with more than 13 years’ experience in health economics and health technology assessment.
I have expertise in economic evaluation across a wide number of disease areas, with some of my recent work covering oncology, gastroenterology, nephrology, and mental health. My experience spans the product lifecycle, from early economic models to global models suited for health technology assessment, as well as models developed for use in local payer negotiations.
My prior experience includes leadership roles in health economics teams at Mtech Access and Parexel.
I have a BSc in Mathematics from the University of Exeter and an MSc in Health Economics from City, University of London.
Featured insights
A selection of external publications
-
The societal value of vaccines: Expert-based conceptual framework and methods Using Covid-19 vaccines as a case study
Read on PubMed -
An Insurance Value Modeling approach that captures the wider value of a novel antimicrobial to health systems, patients, and the population
Read on PubMed -
Improving health evaluations to capture wider value of therapeutics and incentivise innovation
Read on PubMed -
First in class, best in class or a wild card: who will dominate the anti-obesity medication market?
Read on PubMed -
Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals
Read on PubMed -
-
Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
Read on PubMed -
Contributions of diseases and injuries to widening life expectancy inequalities in England from 2001 to 2016: a population-based analysis of vital registration data
Read on PubMed -
-
-
Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records
Read on PubMed -
Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records
Read on PubMed -
Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidence
Read on PubMed -
Eight-year trends in obesity-related complications and health care cost progression in a US population with obesity: A retrospective cohort study
Read on PubMed
